tiprankstipranks
Trending News
More News >
Concord Medical Services (CCM)
NYSE:CCM
US Market

Concord Medical Services (CCM) Ratios

Compare
107 Followers

Concord Medical Services Ratios

CCM's free cash flow for Q2 2025 was ¥-0.02. For the 2025 fiscal year, CCM's free cash flow was decreased by ¥ and operating cash flow was ¥-0.72. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.42 0.46 0.32 0.68 0.73
Quick Ratio
0.41 0.45 0.30 0.60 0.68
Cash Ratio
0.07 0.10 0.03 0.14 0.20
Solvency Ratio
>-0.01 -0.03 -0.04 -0.09 -0.05
Operating Cash Flow Ratio
0.00 -0.19 -0.14 -0.19 -0.45
Short-Term Operating Cash Flow Coverage
0.00 -0.39 -0.27 -0.42 -1.20
Net Current Asset Value
¥ -3.99B¥ -4.12B¥ -3.69B¥ -3.23B¥ -2.90B
Leverage Ratios
Debt-to-Assets Ratio
0.57 0.58 0.54 0.54 0.44
Debt-to-Equity Ratio
-1.71 -1.72 -1.55 -1.74 -1.99
Debt-to-Capital Ratio
2.41 2.38 2.81 2.35 2.01
Long-Term Debt-to-Capital Ratio
80.35 6.26 -18.66 3.97 2.65
Financial Leverage Ratio
-3.01 -2.95 -2.85 -3.22 -4.55
Debt Service Coverage Ratio
-0.25 -0.27 -0.26 -0.52 -0.96
Interest Coverage Ratio
-2.40 -2.75 -2.79 -4.36 -6.21
Debt to Market Cap
987.37 655.27 257.18 182.40 408.22
Interest Debt Per Share
28.02K 28.32K 23.77K 23.08K 58.27K
Net Debt to EBITDA
-10.17 -10.75 -9.41 -7.67 -7.08
Profitability Margins
Gross Profit Margin
-11.44%-20.62%-14.26%-32.28%-11.72%
EBIT Margin
-130.98%-124.07%-86.15%-111.22%-94.38%
EBITDA Margin
-98.02%-90.02%-64.04%-85.12%-74.92%
Operating Profit Margin
-130.98%-138.60%-86.15%-111.22%-94.38%
Pretax Profit Margin
-141.56%-174.39%-103.39%-177.91%-108.98%
Net Profit Margin
-44.60%-80.28%-55.39%-103.72%-55.89%
Continuous Operations Profit Margin
-149.39%-169.83%-98.81%-162.89%-107.63%
Net Income Per EBT
31.50%46.04%53.57%58.30%51.29%
EBT Per EBIT
108.08%125.82%120.00%159.97%115.47%
Return on Assets (ROA)
-2.42%-4.58%-4.92%-8.15%-4.36%
Return on Equity (ROE)
7.22%13.52%14.03%26.27%19.81%
Return on Capital Employed (ROCE)
-11.20%-11.57%-11.29%-10.75%-8.45%
Return on Invested Capital (ROIC)
-8.40%-9.13%-8.52%-8.85%-7.88%
Return on Tangible Assets
-2.77%-5.63%-5.77%-10.49%-5.93%
Earnings Yield
-4485.04%-5391.36%-2504.75%-2973.15%-4435.67%
Efficiency Ratios
Receivables Turnover
6.38 7.50 7.31 3.62 1.27
Payables Turnover
3.63 2.32 4.75 4.26 5.29
Inventory Turnover
29.77 13.85 15.22 7.36 14.25
Fixed Asset Turnover
0.09 0.10 0.13 0.14 0.15
Asset Turnover
0.05 0.06 0.09 0.08 0.08
Working Capital Turnover Ratio
-0.26 -0.31 -0.63 -1.62 -17.29
Cash Conversion Cycle
-30.96 -82.15 -2.92 64.53 244.55
Days of Sales Outstanding
57.24 48.64 49.92 100.72 287.89
Days of Inventory Outstanding
12.26 26.36 23.98 49.58 25.62
Days of Payables Outstanding
100.46 157.15 76.82 85.77 68.96
Operating Cycle
69.50 75.00 73.90 150.30 313.51
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -2.73K -1.90K -1.49K -7.46K
Free Cash Flow Per Share
0.00 -5.55K -2.69K -4.12K -23.25K
CapEx Per Share
0.00 2.82K 794.66 2.64K 15.79K
Free Cash Flow to Operating Cash Flow
0.00 2.03 1.42 2.77 3.12
Dividend Paid and CapEx Coverage Ratio
0.00 -0.97 -2.39 -0.56 -0.47
Capital Expenditure Coverage Ratio
0.00 -0.97 -2.39 -0.56 -0.47
Operating Cash Flow Coverage Ratio
0.00 -0.10 -0.08 -0.07 -0.13
Operating Cash Flow to Sales Ratio
0.00 -1.04 -0.51 -0.46 -0.74
Free Cash Flow Yield
0.00%-14142.61%-3300.09%-3645.95%-18301.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.02 -0.02 -0.04 -0.03 -0.02
Price-to-Sales (P/S) Ratio
0.01 0.01 0.02 0.03 0.01
Price-to-Book (P/B) Ratio
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 >-0.01 -0.03 -0.03 >-0.01
Price-to-Operating Cash Flow Ratio
0.00 -0.01 -0.04 -0.08 -0.02
Price-to-Earnings Growth (PEG) Ratio
>-0.01 >-0.01 <0.01 <0.01 <0.01
Price-to-Fair Value
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Enterprise Value Multiple
-10.18 -10.76 -9.44 -7.71 -7.09
Enterprise Value
3.65B 3.72B 3.25B 3.10B 2.58B
EV to EBITDA
-10.18 -10.76 -9.44 -7.71 -7.09
EV to Sales
9.98 9.69 6.05 6.56 5.32
EV to Free Cash Flow
0.00 -4.60 -8.29 -5.16 -2.31
EV to Operating Cash Flow
0.00 -9.35 -11.75 -14.30 -7.18
Tangible Book Value Per Share
6.10K 2.51K 5.83K 4.66K 22.57K
Shareholders’ Equity Per Share
-15.60K -15.66K -14.57K -12.80K -28.45K
Tax and Other Ratios
Effective Tax Rate
-0.06 0.03 0.04 0.08 0.01
Revenue Per Share
2.55K 2.64K 3.69K 3.24K 10.08K
Net Income Per Share
-1.14K -2.12K -2.04K -3.36K -5.64K
Tax Burden
0.32 0.46 0.54 0.58 0.51
Interest Burden
1.08 1.41 1.20 1.60 1.15
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
1.03 1.05 0.61 0.66 0.72
Stock-Based Compensation to Revenue
0.00 0.00 0.00 -0.01 0.03
Income Quality
0.00 0.61 0.93 0.44 1.32
Currency in CNY